ఫ్లాష్ ఫ్లాష్

Viewers Count

Advertisement

Royal Enfield spares

Advertisement

counterfeit medicines in Indonesia - court ruling - relief to the families of the victims


A court ruling in Indonesia that has allowed families to pursue a lawsuit against a pharmaceutical company following the deaths of at least 12 people who consumed a counterfeit cough syrup produced by the company.

The cough syrup was found to contain diethylene glycol, a toxic substance commonly used in industrial solvents, which can cause kidney failure and other serious health issues if ingested. Dozens of people were hospitalized as a result of consuming the syrup.

Initially, the pharmaceutical company argued that it was not liable for the deaths, as the cough syrup was counterfeit and not produced by the company itself. However, the recent court ruling has allowed the families of the victims to pursue their lawsuit against the company, as evidence showed that the company was aware of the counterfeit products being sold under its brand name and failed to take adequate measures to prevent their distribution.

The case has drawn attention to the issue of counterfeit medicines in Indonesia, where poor regulation and enforcement have allowed fake and potentially dangerous products to be sold to consumers. The government has promised to take action to address the issue, but many remain skeptical that real change will occur.

The court ruling has brought some relief to the families of the victims, who have been seeking compensation for their losses. It also highlights the importance of ensuring that medicines are safe and properly regulated to prevent such tragedies from occurring in the future.

The deaths of at least 12 people in Indonesia have been linked to a cough syrup containing a toxic substance called diethylene glycol, which is commonly used in industrial solvents. Dozens more were hospitalized as a result of consuming the cough syrup.

The Indonesia cough syrup deaths and subsequent court ruling highlights the importance of ensuring that medicines are safe and properly regulated to prevent such tragedies from occurring in the future. It also emphasizes the need for companies to take responsibility for the products that bear their brand name and take appropriate measures to prevent counterfeit products from reaching consumers.


In Association with 
 News9 

Follow us in 




Advertisement